AIP
NMTR

Almanack Investment Partners’s 9 Meters Biopharma NMTR Stock Holding History

Almanack Investment Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,100
Closed -$6K – 977
2022
Q2 		$6K Hold
1,100
– – ﹤0.01% 459
2022
Q1 		$13K Sell
1,100
-355
-24% -$4.85K ﹤0.01% 493
2021
Q4 		$28K Sell
1,455
-588
-29% -$13.2K ﹤0.01% 516
2021
Q3 		$53K Sell
2,043
-567
-22% -$13.4K ﹤0.01% 502
2021
Q2 		$57K Sell
2,610
-13
-0.5% -$319 0.01% 440
2021
Q1 		$61K Buy
+2,623
New +$80.6K 0.01% 430

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Almanack Investment Partners's NMTR Position: Q3 2022 in Review

Almanack Investment Partners sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 1,100 shares — an estimated $6K sold.

Almanack Investment Partners first reported a position in NMTR in Q1 2021 and held it in 6 quarters. The position peaked at $61K in Q1 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • Almanack Investment Partners reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,100 9 Meters Biopharma shares in Q3 2022, an estimated $6K.
  • Almanack Investment Partners first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 6 quarters.
  • Almanack Investment Partners's 9 Meters Biopharma position peaked at $61K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on Almanack Investment Partners's 13F filing for Q3 2022, filed 15 Nov 2022.